Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Targeting Lysine-specific Demethylase 1 to Enhance the Post-transplant Graft-versus-leukemia Effect

EF 2021-22

Résumé
Acute myeloid leukemia (AML) is an aggressive blood cancer with a 5-year survival rate of 21%. AML occurs when the bone marrow produces a large number of unhealthy cells that prevent the growth and functions of normal cells. The only cure for AML patients is to undergo a stem cell transplant where normal blood stem cells from a healthy donor are transplanted into the patients. These donor cells have the ability to prevent AML from re-emerging, but AML still frequently returns after transplant, leading to disease relapse. To reduce relapse and improve the long-term effectiveness of transplants, new treatment options are needed. Lysine-specific demethylase 1 (LSD1) is a protein that has been a promising therapeutic target for treating AML. Blocking the function of LSD1 has also been shown to increase immune cells ability to recognize and kill cancer cells. Therefore, this project aims to study the ability for LSD1 blockers to activate and enhance immune responses against AML in the context of stem cell transplant. We will characterize the underlying molecular mechanisms that contribute to a potentially heightened anti-leukemia immune response. Mice models that mimic the relevant biological environment will also be used to evaluate the safety and efficacy of LSD1 blockers. Eventually, our goal is to gather sufficient experimental evidence to support a clinical trial that further examines the LSD1 blockers ability to prevent relapse after stem cell transplant.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
467033
Name
Yan Yu
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Targeting Lysine-specific Demethylase 1 to Enhance the Post-transplant Graft-versus-leukemia Effect
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adaptive Immunity; Allogenic Transplant; Anti-Tumor Immunity; Cancer Immunotherapy; Epigenetic Therapy; Leukemia; Pre-Clinical Validation; T Cell Immunology; Targeted Therapy; Transplant Immunology
Abstract
Acute myeloid leukemia (AML) is an aggressive blood cancer with a 5-year survival rate of 21%. AML occurs when the bone marrow produces a large number of unhealthy cells that prevent the growth and functions of normal cells. The only cure for AML patients is to undergo a stem cell transplant where normal blood stem cells from a healthy donor are transplanted into the patients. These donor cells have the ability to prevent AML from re-emerging, but AML still frequently returns after transplant, leading to disease relapse. To reduce relapse and improve the long-term effectiveness of transplants, new treatment options are needed. Lysine-specific demethylase 1 (LSD1) is a protein that has been a promising therapeutic target for treating AML. Blocking the function of LSD1 has also been shown to increase immune cells ability to recognize and kill cancer cells. Therefore, this project aims to study the ability for LSD1 blockers to activate and enhance immune responses against AML in the context of stem cell transplant. We will characterize the underlying molecular mechanisms that contribute to a potentially heightened anti-leukemia immune response. Mice models that mimic the relevant biological environment will also be used to evaluate the safety and efficacy of LSD1 blockers. Eventually, our goal is to gather sufficient experimental evidence to support a clinical trial that further examines the LSD1 blockers ability to prevent relapse after stem cell transplant.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yan, Yu
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~